Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus (Q38182646)

30 August 2017

Interplay of infections, autoimmunity, and immunosuppression in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

30 August 2017

1 reference

0 references

3

Andras Perl

1 reference

30 August 2017

Tiffany Caza

1

1 reference

PubMed ID

24471448

30 August 2017

Zachary Oaks

series ordinal

2

1 reference

30 August 2017

28 January 2014

1 reference

International Reviews of Immunology

30 August 2017

34

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 August 2017

33

1 reference

30 August 2017

4

1 reference

30 August 2017

330-363

1 reference

Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

30 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Genetic susceptibility to SLE: recent progress from GWAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Gene-function studies in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Immunopathogenesis and spectrum of infections in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Infection in systemic lupus erythematosus: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

White blood cell count abnormalities and infections in one-year follow-up of 124 patients with SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Hit-Hit and hit-Run: viruses in the playing field of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Infections in outpatients with systemic lupus erythematosus: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Clinical features, prognostic and risk factors of central nervous system infections in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Clinical presentations and outcomes of systemic lupus erythematosus patients with infection admitted to the intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Impaired phagocytosis and susceptibility to infection in pediatric-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Antibodies against C1q in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Lupus diseases associated with hereditary and acquired deficiencies of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Infectious complications in SLE after immunosuppressive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Chronic granulomatous disease as a risk factor for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Neutrophils in the pathogenesis and manifestations of SLE

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Toll-like receptors in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Natural type I interferon-producing cells as a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Neutrophil extracellular traps kill bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

T- and B-cell abnormalities in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Neutrophil extracellular traps: double-edged swords of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Toll-like receptor and RIG-I-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

T-cell and B-cell signaling biomarkers and treatment targets in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

The IL-23/IL-17 axis in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

DAP1, a novel substrate of mTOR, negatively regulates autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Autophagy and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Macroautophagy is deregulated in murine and human lupus T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Metabolic regulation of organelle homeostasis in lupus T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Pharmacotherapy of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Glucocorticoids and invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Infections associated with steroid use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Incidence, risk factors, and outcome of Herpes zoster in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Methotrexate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Infections during low-dose methotrexate treatment in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Infective endocarditis complicating rituximab (anti-CD20 monoclonal antibody) treatment in an SLE patient with a past history of Libman-Sacks endocarditis: a case for antibiotic prophylaxis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Salmonella infections in patients with systemic lupus erythematosus: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Belimumab for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Nitric oxide, mitochondrial hyperpolarization, and T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

N-acetylcysteine: potential for AIDS therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Defective B cell tolerance checkpoints in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Impaired early B cell tolerance in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Herpes simplex virus type 1 encephalitis and unusual retinitis in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Catastrophic antiphospholipid syndrome triggered by fulminant disseminated herpes simplex infection in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Simultaneous herpes simplex virus esophagitis and lupus enteritis in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

The case for Zostavax vaccination in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

EBV persistence in memory B cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

EBV and systemic lupus erythematosus: a new perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) precipitating a systemic lupus erythematosus (SLE) flare

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Kaposi's sarcoma and other manifestations of human herpesvirus 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Kaposi's sarcoma and its associated herpesvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Viral IL-6-induced cell proliferation and immune evasion of interferon activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Rationale for interleukin-6 blockade in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Possible induction of systemic lupus erythematosus by human parvovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Human parvovirus B19 infection: its relationship with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Parvovirus B19 and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Myxovirus antibody increases in human connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Lymphocyte response to virus antigens in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Endogenous retroviral pathogenesis in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

False-positive human immunodeficiency virus testing in patients with lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

T cells as therapeutic targets in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

HIV-associated chronic immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Oxidative stress promotes polarization of human T cell differentiation toward a T helper 2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Cross-talk of the environment with the host genome and the immune system through endogenous retroviruses in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

The mitochondrial fission factor dynamin-related protein 1 modulates T-cell receptor signalling at the immune synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Functional asplenia in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Autosplenectomy and antiphospholipid antibodies in systemic lupus erythematosus: A pathogenetic relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Nocardiosis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Disseminated nocardiosis with initial manifestation mimicking disease flare-up of systemic lupus erythematosus in an SLE patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Subretinal abscess due to Nocardia farcinica resistant to trimethoprim- sulfamethoxazole in a patient with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Disseminated Nocardia infection presenting as hemorrhagic pustules and ecthyma in a woman with systemic lupus erythematosus and antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Fungal leukocytoclastic vasculitis as a presentation of systemic vasculitis in a patient with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Cryptococcal meningitis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Concurrent presentation of cryptococcal meningoencephalitis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Invasive aspergillosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Aspergillus peritonitis in a lupus patient on chronic peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Fulminant antiphospholipid antibody syndrome complicated by Aspergillus tracheobronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Infections in the lupus patient: perspectives on prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Mucormycosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

The human Ku autoantigen shares amino acid sequence homology with fungal, but not bacterial and viral, proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Disseminated Strongyloides in systemic lupus erythematosus and antiphospholipid antibody syndrome: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Visceral leishmaniasis mimicking autoimmune hepatitis, primary biliary cirrhosis, and systemic lupus erythematosus overlap

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Sera of patients with systemic lupus erythematosus react with plasmodial antigens and can inhibit the in vitro growth of Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Toxoplasmosis and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Toxoplasma infection in systemic lupus erythematosus mimicking lupus cerebritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Role of Helicobacter pylori infection in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Vaccine against autoimmune disease: can helminths or their products provide a therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Hay fever, hygiene, and household size

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

A worm's eye view of the immune system: consequences for evolution of human autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Helminth therapies: translating the unknown unknowns to known knowns

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Infectious antibodies in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Safety of vaccination of patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Clinical and Antibody Responses After Influenza Immunization in Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Increased incidence of herpes zoster among patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Systemic lupus erythematosus following HPV immunization or infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Systemic lupus erythematosus: a consideration for antimicrobial prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Reactivation of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Mannose-binding protein gene polymorphism in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

Ovarian histoplasmosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

High TNF-alpha and IL-8 levels predict low blood dendritic cell counts in primary cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

The development of systemic lupus erythematosus following interferon-α therapy for hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2013.863305

10.3109/08830185.2013.863305

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24471448